Retatrutide vs Tirzepatide vs Semaglutide (Ozempic): GLP-1 Wars — Updated Review (2026)

By Dr Frank Yap, MD -
The landscape of obesity treatment has evolved dramatically with the introduction of advanced medical therapeutics like retatrutide (RETA, LY3437943), tirzepatide (Mounjaro), and semaglutide (Ozempic).

Glucagon-like peptide-1 receptor agonists and co-agonists, originally developed to manage type 2 diabetes, have shown remarkable efficacy in promoting weight loss, making them game-changers for obesity management. However, each drug has unique mechanisms, benefits, and potential applications, including emerging roles in cancer prevention.

This article compares their mechanisms, clinical efficacy, broader health benefits, safety profiles, regulatory status, and practical considerations to help patients, clinicians, and informed readers understand how they stack up in 2026.

Update: Are GLP-1s the first longevity drugs? (Nature 2025)

Ozempic vs Wegovy vs Rybelsus
Credit: GoodRx Health

Mechanism of Action

  • Semaglutide: Semaglutide (Ozempic and Wegovy) is a glucagon-like peptide-1 receptor agonist (GLP-1 RA). It mimics the action of GLP-1, a hormone that enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. Marketed as Ozempic for diabetes and Wegovy for weight loss, semaglutide primarily targets the GLP-1 receptor to regulate blood sugar and promote satiety. In simple terms, it suppresses appetite.
  • Tirzepatide: Tirzepatide, sold as Mounjaro (by Eli Lilly), is a dual agonist that targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. GIP is another incretin hormone that enhances insulin secretion and may improve fat metabolism. This dual action amplifies tirzepatide’s effects on glucose control and weight loss compared to GLP-1-only therapies like semaglutide.
    In simple terms, it suppresses appetite and boosts metabolism.
  • Retatrutide: Retatrutide takes it a step further as a triple agonist, targeting GLP-1, GIP, and glucagon receptors. The addition of glucagon receptor agonism increases energy expenditure by stimulating thermogenesis and fat oxidation, making retatrutide a potent candidate for weight loss. This unique mechanism also contributes to its emerging role in cancer prevention, as discussed in
    recent studies. In simple terms, it suppresses appetite, boosts metabolism, and promotes fat burning.
    • "Triple–hormone-receptor agonist retatrutide, showed unprecedented efficacy in treating obesity, with 24% weight loss over 48 weeks."(NEJM 2023)
    • "Triple G agonists (retatrutide) could provide a bridge to more permanent surgical weight loss or potentially augment surgical efficacy." (NEJM 2023)
    • "Beyond glycemic control and weight reduction, retatrutide shows promise in mitigating cardiovascular risk factors and addressing non-alcoholic fatty liver disease, expanding its potential impact on metabolic health." (European Journal of Pharmacology 2024)

Weight Loss Efficacy

  • Semaglutide: In clinical trials like the STEP program, semaglutide (Wegovy) achieved an average weight loss of 15-20% of body weight over 68 weeks at a 2.4 mg weekly dose. It’s highly effective for many patients but may plateau for some, particularly those with higher baseline weights.
  • Tirzepatide: Tirzepatide has shown superior weight loss compared to semaglutide in head-to-head trials like SURPASS. At its highest dose (15 mg weekly), tirzepatide resulted in 20-25% body weight reduction over 72 weeks, with some patients losing up to 50 pounds. The dual GIP/GLP-1 action likely contributes to its enhanced efficacy.
  • Retatrutide: Retatrutide is the newest contender and has demonstrated unprecedented weight loss in early-phase trials. In a phase 2 study, patients on the highest dose (12 mg weekly) achieved up to 24.2% weight loss over 48 weeks—outpacing both semaglutide and tirzepatide in shorter timeframes. Some participants lost nearly 30% of their body weight, approaching the efficacy of bariatric surgery. The triple-agonist mechanism, particularly glucagon’s role in boosting metabolism, sets retatrutide apart.
Source: eClinicalMedicine 2024

Additional Health Benefits

  • Semaglutide: Beyond weight loss, semaglutide reduces cardiovascular risk in patients with type 2 diabetes (as shown in the SUSTAIN trials) and improves glycemic control. Preclinical studies also suggest modest anti-tumor effects, with a 4-fold reduction in pancreatic tumor volume in mouse models.
  • Tirzepatide: Tirzepatide offers similar cardiovascular benefits and superior glycemic control compared to semaglutide, thanks to its GIP agonism. It also improves lipid profiles, reducing triglycerides and increasing HDL cholesterol. However, its effects on cancer are less studied.
  • Retatrutide: Retatrutide’s triple-agonist action provides unique benefits, including significant improvements in liver fat reduction (up to 90% in some patients), which is critical for non-alcoholic fatty liver disease (NAFLD). Most notably, retatrutide has shown profound anti-tumor effects in preclinical models, with a 14-fold reduction in pancreatic tumor volume, a 17-fold reduction in lung tumor volume, and enhanced chemotherapy efficacy in obese triple-negative breast cancer (TNBC) models. These effects are linked to immune reprogramming and inhibition of the hexosamine biosynthetic pathway (HBP) and EIF3H/YAP axis, suggesting a potential role in reducing obesity-associated cancer risk.
  • Additionally, Retatrutide could be repurposed as a potential cancer treatment as well:

Side Effects and Tolerability

  • Semaglutide: Common side effects include nausea, vomiting, diarrhea, and constipation, which typically subside over time. There’s a rare risk of pancreatitis and a potential association with thyroid C-cell tumors (based on rodent studies), though human data is inconclusive.
  • Tirzepatide: Tirzepatide shares a similar side effect profile to semaglutide, with gastrointestinal issues being the most common. However, its dual agonism may lead to slightly higher rates of nausea in some patients. Like semaglutide, it carries a warning for thyroid tumors.
  • Retatrutide: As a triple agonist, retatrutide also causes gastrointestinal side effects, but early data suggest a higher incidence of mild-to-moderate nausea and vomiting, likely due to its glucagon component. Some patients experience transient increases in heart rate, a known effect of glucagon receptor agonism. Long-term safety data, including cancer risk, is still under investigation, but its anti-tumor effects in preclinical models are promising.
In a 2025 paper by Kim et al, adverse drug reaction patterns of liraglutide, semaglutide and tirzepatide—glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were evaluated for their real-world safety. Tirzepatide had fewer reports of adverse drug reactions compared with the other two drugs, and its pharmacovigilance association strength was the lowest. Semaglutide, however, was significantly associated with several unusual adverse events, including suicidal ideation and behaviour, hair loss and vision loss.

Cost and Accessibility

  • Semaglutide: Widely available as Ozempic and Wegovy, semaglutide is expensive without insurance (around $1,300/month in the U.S.). Generic versions are not yet available, but its established market presence makes it more accessible than newer drugs.
  • Tirzepatide: Mounjaro is similarly priced (approximately $1,200/month), though insurance coverage varies. Its newer status means it may be harder to access in some regions, but Eli Lilly has expanded production to meet demand.
  • Retatrutide: Still in clinical development, retatrutide is not yet commercially available as of April 2025. Pricing is unknown, but given its advanced mechanism, it may be costlier than semaglutide and tirzepatide upon launch. Access will likely be limited until phase 3 trials conclude and regulatory approval is granted.

Availability & Eli Lilly’s Role

  • Semaglutide: Already approved, widely available as Ozempic® and Wegovy®.
  • Tirzepatide: Approved as Mounjaro®, gaining strong traction globally.
  • Retatrutide: Still in clinical trials under Eli Lilly. If results continue to impress, it could hit the market in the next few years, potentially setting a new gold standard in weight loss peptides.
Eli Lilly is positioning Retatrutide as the next breakthrough, possibly surpassing both Semaglutide and Tirzepatide in effectiveness.

Related: Top 10 Pharmaceutical Companies by Revenue and Market Cap in 2025

Regulatory Status & Accessibility

  • Semaglutide: Widely FDA-approved for diabetes (Ozempic) and obesity (Wegovy) with broad clinical use.

  • Tirzepatide: FDA-approved for type 2 diabetes (Mounjaro) and obesity (Zepbound) — available in clinical practice. Drugs.com

  • Retatrutide: Still investigational and not yet FDA-approved as of early 2026. Commercial availability and pricing remain uncertain until regulatory decisions are complete. Drugs.com

Which Drug Is Right for You?

  • Choose Semaglutide if you’re looking for a well-established option with proven weight loss and cardiovascular benefits, and you prefer a drug with a longer safety track record.
  • Choose Tirzepatide if you want greater weight loss potential and improved glycemic control, especially if you have type 2 diabetes or need better lipid management.
  • Choose Retatrutide (once available) if you’re seeking maximum weight loss and are at high risk for obesity-associated cancers, given its promising anti-tumor effects. However, you’ll need to weigh its side effect profile and await its market availability.

Conclusion

Retatrutide, tirzepatide, and semaglutide represent a new era in obesity management, each with distinct mechanisms and benefits. Semaglutide offers a reliable, well-studied option; tirzepatide provides enhanced weight loss and metabolic benefits; and retatrutide, though not yet available, promises unparalleled weight loss and potential cancer risk reduction. As research progresses, these drugs may redefine how we approach obesity and its associated comorbidities, offering hope to millions worldwide. Consult your healthcare provider to determine which option aligns best with your health goals.

FAQs About Retatrutide vs Semaglutide vs Tirzepatide

1. What makes Retatrutide different from Semaglutide and Tirzepatide?

Retatrutide is a triple agonist, meaning it activates three key receptors instead of one (Semaglutide) or two (Tirzepatide). This could explain why early trials show even greater weight loss results.

2. Is Retatrutide approved for use yet?

Not yet. Retatrutide is still in clinical trials under Eli Lilly. Semaglutide and Tirzepatide, however, are already approved and available as prescription medications.

3. Which peptide is best for weight loss?

Current data suggests Retatrutide may offer the strongest weight loss effects, but since it’s still in testing, Semaglutide and Tirzepatide remain the practical options for now.

4. Are side effects different between these peptides?

All three can cause gastrointestinal effects like nausea or diarrhea. Tirzepatide and Retatrutide sometimes show stronger appetite suppression, while Semaglutide is considered the most stable in terms of long-term safety data.

5. Where can I learn about Retatrutide dosing?

Check out our guide: Retatrutide Dosage Insights: What Studies Reveal & Why Calculators Can Mislead. It breaks down how researchers explore dosing while avoiding misleading charts and calculators online.


References:

GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review (eClinicalMedicine 2024)

SELECT trial: Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design (American Heart Journal 2020)

SUSTAIN 10 trial: Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes. (Diabetes & Metabolism 2020)

SURMOUNT 4 trial: Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (JAMA 2023)

SURMOUNT 2 trial: Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (Lancet 2023)


Related: 


Ozempic vs Wegovy vs Mounjaro vs Zepbound: Key Differences, Weight Loss Results & Which One Works Best in 2026


DROP: Oral Retatrutide for Weight-Loss


Skip the weekly injections and try this breakthrough solution that supports metabolic health by promoting GLP-1, GIP, and glucagon receptors for less cravings.

DROP (Oral Retatrutide Drops) offers a solution designed to work with your body to help manage weight and support a healthy metabolism.


Paired with healthy habits like balanced nutrition and regular movement, DROP can help support sustainable weight management.

Your healthier alternative is here.

No needles. No restrictive diets. Just a smarter approach to weight management.

Available on The Wellness Company's website. Here is the link: DROP.

Comments

Post a Comment

Labels

Show more

Popular posts from this blog

Best Vitamin D3 + K2 Supplements in 2026: Doctor-Reviewed Picks for Bone, Heart & Immune Health

By Dr Frank Yap, MD -
Image
Vitamin D3 and Vitamin K2 are two of the most commonly deficient—and misunderstood—nutrients today. While Vitamin D improves calcium absorption, Vitamin K2 determines where that calcium actually goes . That’s why taking Vitamin D without K2 may be incomplete—and in some cases counterproductive. After reviewing ingredient quality, dosing accuracy, brand transparency, and real-world user feedback, the following are the best Vitamin D3 + K2 supplements available in 2026 . Most people in the United States consume less than recommended amounts of vitamin D . An analysis of data from the 2017–2018 National Health and Nutrition Examination Survey (NHANES) found that average daily vitamin D intakes from foods and beverages were 4.3 mcg in men, 3.8 mcg in women, and 5 mcg (200 IU) in children aged 2–19 years ( NHANES 2017 - 2018 ). Why Trust This Guide? This review prioritizes supplements that meet four non-negotiable criteria : Uses Vitamin D3 (cholecalciferol) — not D2 Includes Vitam...
Read more

Ivermectin and Fenbendazole in the Treatment of Psoriasis? A Case Series of 13 Patients (2026)

By Dr Frank Yap, MD -
Image
Abstract Psoriasis is a chronic autoimmune condition affecting approximately 7.5 million individuals in the United States, with significant economic, physical, and psychological burdens. This case series reports on 13 patients who experienced notable improvements in psoriasis symptoms following treatment with ivermectin and/or fenbendazole, antiparasitic agents repurposed for this indication. Cases were derived from self-reported testimonials shared on social media platforms. Treatment durations ranged from 3 days to 3 months, with dosages varying between 6 mg ivermectin twice daily and combinations with fenbendazole. Rapid resolution of skin lesions was observed in most cases, with some achieving near-complete clearance. While these anecdotal reports suggest potential therapeutic efficacy, controlled clinical trials are warranted to validate these findings and elucidate underlying mechanisms. Introduction Psoriasis is a chronic inflammatory disorder characterized by hyperproliferation...
Read more

7 Best Cetylpyridinium Chloride Mouthwash Brands 2025

By Dr Frank Yap, MD -
Image
A meta-analysis of 3 studies (C19early 2025) concluded that CPC (CetylPyridinium Chloride) may significantly lower risk with  viral clearance . One study shows significant benefit. Meta analysis using the most serious outcome reported shows 83% [6‑97%] lower risk . Results are consistent with early treatment being more effective than late treatment. A study, published in Nature ( Takeda 2022 ) concluded that CPC (CetylPyridinium Chloride) may inhibit SARS-CoV-2 infection even at lower concentrations. Another team of international scientists has also demonstrated the usefulness of cetylpyridinium chloride-containing mouthwashes in inhibiting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and reducing the risk of viral transmission. The study is published in the Journal of Medical Microbiology (2022). A scientific review, published in the  Journal of Formosan Medical Association  (2022) also concluded that mouthwash containing CPC shows potential fo...
Read more

Ozempic vs Wegovy vs Mounjaro vs Zepbound: Key Differences, Weight Loss Results & Which One Works Best in 2026

By Dr Frank Yap, MD -
Image
If you’re considering injectable medications for weight loss or type 2 diabetes , you’ve probably heard of Ozempic, Wegovy, Mounjaro, and Zepbound . These drugs are reshaping obesity and diabetes care, but with multiple options on the market, it can be confusing to know which is best for your goals. In this guide, we break down each medication, compare their weight-loss potential, diabetes benefits, and side effects — all in a simple, easy-to-digest format. What These Drugs Are & How They Work All four medications are injectables , but they differ in mechanism, dosage, and approval purpose : Ozempic & Wegovy: Both contain semaglutide , a GLP-1 receptor agonist. GLP-1 slows digestion, increases fullness, and helps regulate blood sugar. Mounjaro & Zepbound: Both contain tirzepatide , a dual GIP + GLP-1 receptor agonist. This dual action enhances insulin secretion and appetite suppression, often producing stronger weight loss. Key difference: Ozempic and Mounjaro are primari...
Read more

9 Best Vitamin D3, K2 and Magnesium Supplements 2025

By Dr Frank Yap, MD -
Image
Magnesium, vitamin D and Vitamin K2 are vitamin and minerals that are vital to several bodily processes. Though they occur naturally in a variety of foods, many people take supplements to help increase their intake. Magnesium, Vitamin D3 and Vitamin K Dosage The typical daily dosage recommendations for these nutrients are: Magnesium: 400–500 mg Vitamin D3: 800 IU (20 mcg)  Vitamin K : 120mcg Food With Magnesium, Vitamin D3 and Vitamin K Magnesium: dark chocolate, avocados, nuts, leafy vegetables, and legumes Vitamin D3: avocados, nuts, seeds, full-fat dairy products and eggs Vitamin K: turnips, spinach, kale, brocolli, soybeans, carrots, Chicken If you’re concerned you may be deficient in any of these nutrients, talk to a health professional who can test your levels and determine whether you should eat more of these foods or take a supplement. Benefits and uses 1. May support bone health Magnesium  plays a key role in converting vitamin D into its active form, which aids calci...
Read more

GLP‑1 Drugs for Alzheimer’s Disease: Can Semaglutide and Liraglutide Reduce Dementia Risk? (2026 Evidence Review)

By Dr Frank Yap, MD -
Image
Quick Take GLP‑1 receptor agonists (such as semaglutide, liraglutide, dulaglutide) are not approved treatments for Alzheimer’s disease (AD). However, growing epidemiologic, preclinical, and early clinical evidence suggests they may reduce Alzheimer’s risk and slow cognitive decline indirectly by improving insulin signaling, neuroinflammation, vascular health, and mitochondrial function. This article reviews the science without hype — what looks promising, what’s proven, and what remains unknown. Why GLP‑1 Entered the Alzheimer’s Conversation Alzheimer’s disease is increasingly understood as a metabolic–inflammatory brain disorder , not just an amyloid problem. Hallmarks include: Brain insulin resistance (“ type 3 diabetes ” hypothesis) Mitochondrial dysfunction Chronic neuroinflammation Cerebrovascular impairment GLP‑1 drugs were originally developed for type 2 diabetes but have systemic effects highly relevant to AD pathophysiology. What Are GLP‑1 Receptor Agonists? GLP‑1 receptor ago...
Read more

How Oral Retatrutide in DROP Delivers Up to 24% Weight Loss – Clinical Updates and Real Results 2025

By Dr Frank Yap, MD -
Image
Retatrutide: A Triple‑Agonist for Obesity and Metabolic Diseases Introduction Retatrutide (LY3437943; Eli Lilly) is a novel investigational agent that simultaneously activates three incretin‑related receptors—the glucose‑dependent insulinotropic polypeptide (GIP), glucagon‑like peptide‑1 (GLP‑1), and glucagon receptors. This “triple agonist” approach aims to combine potent glucose control and profound weight‑loss benefits while addressing metabolic dysfunction beyond the capabilities of current single or dual incretin mimetics (e.g., semaglutide or tirzepatide). Mechanism of Action Retatrutide binds and activates GIP, GLP‑1, and glucagon receptors with balanced agonism in vitro. GLP‑1R stimulation: enhances glucose‑dependent insulin secretion, slows gastric emptying, and reduces appetite.  GIPR activation:  synergizes Beta‑cell function and amplifies postprandial insulin and increases energy expenditure and fatty acid oxidation, offsetting the potential hyperglycemia of pure glucag...
Read more

17 Best Natural Ozempic Alternatives 2026 (Resource Guide)

By Dr Frank Yap, MD -
Image
Some of the best natural alternatives to Ozempic include berberine, a supplement that has shown potential in managing blood sugar and promoting weight loss, often referred to as “nature’s Ozempic” in wellness communities. High-fiber foods also play a crucial role by helping to control appetite and improve metabolic health. Other natural options include psyllium husk, which provides soluble fiber supporting satiety and digestive health, and curcumin, known for its anti-inflammatory properties, which may aid metabolic balance. Additionally, green tea extract, magnesium, protein-rich foods, and lifestyle factors like adequate sleep and stress reduction contribute to weight management.  However, none of these natural alternatives are as potent or fast-acting as Ozempic itself, and their effects can vary widely among individuals. It is important to consult a healthcare provider before starting any supplement regimen, especially for managing blood sugar or weight loss. The 2023 rep...
Read more

9 Best Calcium, Magnesium, Vitamin D3 and K2 Supplements 2025

By Dr Frank Yap, MD -
Image
Calcium, magnesium, vitamin D and Vitamin K2 are vitamin and minerals that are vital to several bodily processes. Though they occur naturally in a variety of foods, many people take supplements to help increase their intake. Benefits and uses 1. May support bone health Calcium is the main mineral in your bones, which hold more than 99% of your body’s calcium stores. Your body is constantly regenerating its bone tissue, so it’s important to consume an adequate amount of this mineral daily ( bones.nih.gov ). Magnesium plays a key role in converting vitamin D into its active form, which aids calcium absorption ( Trusted Source ). Therefore, you can minimize your vitamin D requirement by making sure you’re also getting enough magnesium. Research has confirmed higher magnesium intake helps reduce your risk of vitamin D deficiency by activating more of it.  A  groundbreaking 2017 review  compiled over 80 studies that show vitamin D3 and K2 together might be greater than...
Read more

9 Best Anti Aging Skincare Hong Kong 2025

By Dr Frank Yap, MD -
Image
It’s natural to have complex feelings about noticing signs of aging. You can embrace the beauty and privilege that it is to age, while also not love all of the physical changes that come along with it.  If you’d like to soften these signs but don’t want to go the injectables route, there are non-invasive products that can help. In the world of beauty products, there's perhaps no category more saturated than the anti-aging market. What to Look for in an Anti-Aging Product a. Vitamin C An antioxidant powerhouse, vitamin C is directly involved with collagen production in the body. Vitamin C is beneficial in anti-aging products for several reasons: It protects skin from environmental stressors, promotes cell turnover, and can fade dark spots which contribute to the appearance of aging skin. Products containing vitamin C can irritate sensitive skin, so be sure to start out using a low concentration if your skin is reactive. b. Retinoids Retinoids are a category of ingredients, and retin...
Read more

Archive

Show more